Cargando…
Reversible Acute Lung Injury due to Bleomycin
Bleomycin is a unique antibiotic agent with cytotoxic activity and is used successfully in various malignant diseases, such as Hodgkin lymphoma and germ cell tumors. Drug-induced lung injury (DILI) is one of the major limitations of bleomycin administration in particular clinical settings. The incid...
Autores principales: | Ghalamkari, Marziyeh, Khatuni, Mahdi, Toogeh, Gholamreza, Haghighi, Sepehr, Taherkhani, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Research Institute of Tuberculosis and Lung Disease
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985134/ https://www.ncbi.nlm.nih.gov/pubmed/36879731 |
Ejemplares similares
-
Disseminated tuberculosis with myelofibrosis presentation: a case report
por: Khatuni, Mahdi, et al.
Publicado: (2021) -
A patient with Multiple myeloma and Renal cell carcinoma
por: Shahi, Farhad, et al.
Publicado: (2016) -
A Survey of Infection in Allogenic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
por: Safayi, S. R., et al.
Publicado: (2018) -
Nintedanib treatment for bleomycin-induced lung injury - First report
por: Rnjak, Dina, et al.
Publicado: (2023) -
Myelodysplastic Syndrome with 6q Deletion as the Sole Chromosome Abnormality in an Iranian Patient: A Case Report with Review of Literature
por: Ferdowsi, Shirin, et al.
Publicado: (2013)